BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34224595)

  • 81. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
    Chaudhuri AA; Binkley MS; Rigdon J; Carter JN; Aggarwal S; Dudley SA; Qian Y; Kumar KA; Hara WY; Gensheimer M; Nair VS; Maxim PG; Shultz DB; Bush K; Trakul N; Le QT; Diehn M; Loo BW; Guo HH
    Radiother Oncol; 2016 Jun; 119(3):454-60. PubMed ID: 27267049
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
    Oetzel D; Schraube P; Hensley F; Sroka-Pérez G; Menke M; Flentje M
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):455-60. PubMed ID: 7673033
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy.
    Jia W; Gao Q; Wang M; Li J; Jing W; Yu J; Zhu H
    Radiat Oncol; 2021 Feb; 16(1):41. PubMed ID: 33622352
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer.
    Moreno M; Aristu J; Ramos LI; Arbea L; López-Picazo JM; Cambeiro M; Martínez-Monge R
    Clin Transl Oncol; 2007 Sep; 9(9):596-602. PubMed ID: 17921108
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Isotoxic dose escalation in the treatment of lung cancer by means of heterogeneous dose distributions in the presence of respiratory motion.
    Baker M; Nielsen M; Hansen O; Jahn JW; Korreman S; Brink C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):849-55. PubMed ID: 21570211
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer.
    Uno T; Isobe K; Kawakami H; Ueno N; Kawata T; Yamamoto S; Sekine Y; Iyoda A; Iizasa T; Fujisawa T; Shigematsu N; Ito H
    Int J Clin Oncol; 2006 Feb; 11(1):55-9. PubMed ID: 16508730
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
    Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J
    Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The use of lung dose-volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma.
    Clenton SJ; Fisher PM; Conway J; Kirkbride P; Hatton MQ
    Clin Oncol (R Coll Radiol); 2005 Dec; 17(8):599-603. PubMed ID: 16372484
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genetic variants of SP-D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy.
    Xu L; Jiang J; Li Y; Zhang L; Li Z; Xian J; Jiang C; Diao Y; Su X; Xu H; Zhang Y; Zhang T; Yang Z; Tan B; Li H
    Cancer Med; 2019 May; 8(5):2599-2611. PubMed ID: 30897289
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.
    Tucker SL; Jin H; Wei X; Wang S; Martel MK; Komaki R; Liu HH; Mohan R; Chen Y; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):691-8. PubMed ID: 19836159
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer.
    Liu Y; Wang W; Shiue K; Yao H; Cerra-Franco A; Shapiro RH; Huang KC; Vile D; Langer M; Watson G; Bartlett G; Ai H; Sheski F; Jin JY; Zellars R; Fu P; Lautenschlaeger T; Kong FS
    Radiother Oncol; 2021 Mar; 156():231-238. PubMed ID: 33096168
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors.
    Roach M; Gandara DR; Yuo HS; Swift PS; Kroll S; Shrieve DC; Wara WM; Margolis L; Phillips TL
    J Clin Oncol; 1995 Oct; 13(10):2606-12. PubMed ID: 7595714
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Accuracy and Utility of Deformable Image Registration in (68)Ga 4D PET/CT Assessment of Pulmonary Perfusion Changes During and After Lung Radiation Therapy.
    Hardcastle N; Hofman MS; Hicks RJ; Callahan J; Kron T; MacManus MP; Ball DL; Jackson P; Siva S
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):196-204. PubMed ID: 26279034
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Should regional ventilation function be considered during radiation treatment planning to prevent radiation-induced complications?
    Lan F; Jeudy J; Senan S; van Sornsen de Koste JR; D'Souza W; Tseng HH; Zhou J; Zhang H
    Med Phys; 2016 Sep; 43(9):5072. PubMed ID: 27587037
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Functional lung imaging in radiation therapy for lung cancer: A systematic review and meta-analysis.
    Bucknell NW; Hardcastle N; Bressel M; Hofman MS; Kron T; Ball D; Siva S
    Radiother Oncol; 2018 Nov; 129(2):196-208. PubMed ID: 30082143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.